A descriptive survey on the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for pelvic fractures at US level I trauma centers
| Autor: | Mark Lieser, Stephanie Jarvis, Chad Corrigan, Kaysie L. Banton, Nimesh S. A. Patel, Charles W. Mains, David Bar-Or, Michael Kelly, Matthew M. Carrick |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Pelvic fracture management First line Descriptive survey lcsh:Surgery 030230 surgery 03 medical and health sciences 0302 clinical medicine medicine.artery medicine Orthopedics and Sports Medicine Resuscitative endovascular balloon occlusion of the aorta (REBOA) Aorta Level I trauma center medicine.diagnostic_test business.industry Research 030208 emergency & critical care medicine Interventional radiology lcsh:RD1-811 medicine.disease Surgery Advanced trauma life support Anesthesiology and Pain Medicine Blood pressure Balloon occlusion Pelvic fracture business |
| Zdroj: | Patient Safety in Surgery, Vol 13, Iss 1, Pp 1-9 (2019) Patient Safety in Surgery |
| ISSN: | 1754-9493 |
| Popis: | BackgroundResuscitative endovascular balloon occlusion of the aorta (REBOA) is not widely adopted for pelvic fracture management. Western Trauma Association recommends REBOA for hemodynamically unstable pelvic fractures, whereas Eastern Association for the Surgery of Trauma and Advanced Trauma Life Support do not.MethodUtilizing a prospective cross-sectional survey, all 158 trauma medical directors at American College of Surgeons-verified Level I trauma centers were emailed survey invitations. The study aimed to determine the rate of REBOA use, REBOA indicators, and the treatment sequence of REBOA for hemodynamically unstable pelvic fractures.ResultsOf those invited, 25% (40/158) participated and 90% (36/40) completed the survey. Nearly half of trauma centers [42% (15/36)] use REBOA for pelvic fracture management. All participants included hemodynamic instability as an indicator for REBOA placement in pelvic fractures. In addition to hemodynamic instability, 29% (4/14) stated REBOA is used for patients who are ineligible for angioembolization, 14% (2/14) use REBOA when interventional radiology is unavailable, 7% (1/14) use REBOA for patients with a negative FAST. Fifty percent (7/14) responded that hemodynamically unstable pelvic fractures exclusively indicates REBOA placement. Hemodynamic instability for pelvic fractures was most commonly defined as systolic blood pressure of ConclusionsThere is little consensus on REBOA use for pelvic fractures at US Level I Trauma Centers, except that hemodynamically unstable pelvic fractures consistently indicated REBOA use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |